APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sevoflurane

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Selected research

Market Outlook & Growth Opportunities

Global Sevoflurane Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchSevoflurane Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sevoflurane Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Sevoflurane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sevoflurane Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sevoflurane Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Europe is the largest Sevoflurane market with about 40% market share. Asia is follower, accounting for about 25% market share.

Read the full market overview

The key players are Abbott, Baxter, Maruishi, Jiangsu Hengrui, Lunan etc. Top 3 companies occupied about 63% market share.

This report provides an overview of the global Sevoflurane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sevoflurane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sevoflurane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sevoflurane market size, projected growth trends, production technologies, key applications, and end-use industries.

Sevoflurane Segment by Company

Abbott

Baxter

Maruishi

Jiangsu Hengrui

Lunan

Sevoflurane Segment by Type

Generic Drug

Original Drug

Sevoflurane Segment by Application

Hospitals

Other Medical Institutions

Sevoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sevoflurane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sevoflurane market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sevoflurane significant trends, drivers, influence factors in global and regions.

6. To analyze Sevoflurane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sevoflurane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sevoflurane industry.

Chapter 3: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sevoflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sevoflurane in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sevoflurane Industry Trends Table 2. Sevoflurane Industry Drivers Table 3. Sevoflurane Industry Opportunities and Challenges Table 4. Sevoflurane Industry Restraints Table 5. Global Sevoflurane Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sevoflurane Revenue Share by Company (2021-2026) Table 7. Global Sevoflurane Sales Volume by Company (K t) & (2021-2026) Table 8. Global Sevoflurane Sales Volume Share by Company (2021-2026) Table 9. Global Sevoflurane Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Sevoflurane Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sevoflurane Key Company Manufacturing Base & Headquarters Table 12. Global Sevoflurane Company, Product Type & Application Table 13. Global Sevoflurane Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Generic Drug Table 18. Significant Companies of Original Drug Table 19. Global Sevoflurane Sales Volume by Type 2021 VS 2025 VS 2032 (K t) Table 20. Global Sevoflurane Sales Volume by Type (2021-2026) & (K t) Table 21. Global Sevoflurane Sales Volume by Type (2027-2032) & (K t) Table 22. Global Sevoflurane Sales Volume Share by Type (2021-2026) Table 23. Global Sevoflurane Sales Volume Share by Type (2027-2032) Table 24. Global Sevoflurane Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sevoflurane Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sevoflurane Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sevoflurane Sales Value Share by Type (2021-2026) Table 28. Global Sevoflurane Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Other Medical Institutions Table 31. Global Sevoflurane Sales Volume by Application 2021 VS 2025 VS 2032 (K t) Table 32. Global Sevoflurane Sales Volume by Application (2021-2026) & (K t) Table 33. Global Sevoflurane Sales Volume by Application (2027-2032) & (K t) Table 34. Global Sevoflurane Sales Volume Share by Application (2021-2026) Table 35. Global Sevoflurane Sales Volume Share by Application (2027-2032) Table 36. Global Sevoflurane Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Sevoflurane Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Sevoflurane Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Sevoflurane Sales Value Share by Application (2021-2026) Table 40. Global Sevoflurane Sales Value Share by Application (2027-2032) Table 41. Global Sevoflurane Sales by Region: 2021 VS 2025 VS 2032 (K t) Table 42. Global Sevoflurane Sales by Region (2021-2026) & (K t) Table 43. Global Sevoflurane Sales Market Share by Region (2021-2026) Table 44. Global Sevoflurane Sales by Region (2027-2032) & (K t) Table 45. Global Sevoflurane Sales Market Share by Region (2027-2032) Table 46. Global Sevoflurane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Sevoflurane Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Sevoflurane Sales Value Share by Region (2021-2026) Table 49. Global Sevoflurane Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Sevoflurane Sales Value Share by Region (2027-2032) Table 51. Global Sevoflurane Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Sevoflurane Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Sevoflurane Sales by Country: 2021 VS 2025 VS 2032 (K t) Table 54. Global Sevoflurane Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Sevoflurane Sales by Country (2021-2026) & (K t) Table 56. Global Sevoflurane Sales Market Share by Country (2021-2026) Table 57. Global Sevoflurane Sales by Country (2027-2032) & (K t) Table 58. Global Sevoflurane Sales Market Share by Country (2027-2032) Table 59. Global Sevoflurane Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Sevoflurane Sales Value Market Share by Country (2021-2026) Table 61. Global Sevoflurane Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Sevoflurane Sales Value Market Share by Country (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Sevoflurane Sales (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Abbott Sevoflurane Product Portfolio Table 67. Abbott Recent Development Table 68. Baxter Company Information Table 69. Baxter Business Overview Table 70. Baxter Sevoflurane Sales (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Baxter Sevoflurane Product Portfolio Table 72. Baxter Recent Development Table 73. Maruishi Company Information Table 74. Maruishi Business Overview Table 75. Maruishi Sevoflurane Sales (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Maruishi Sevoflurane Product Portfolio Table 77. Maruishi Recent Development Table 78. Jiangsu Hengrui Company Information Table 79. Jiangsu Hengrui Business Overview Table 80. Jiangsu Hengrui Sevoflurane Sales (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Jiangsu Hengrui Sevoflurane Product Portfolio Table 82. Jiangsu Hengrui Recent Development Table 83. Lunan Company Information Table 84. Lunan Business Overview Table 85. Lunan Sevoflurane Sales (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Lunan Sevoflurane Product Portfolio Table 87. Lunan Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Sevoflurane Distributors List Table 91. Sevoflurane Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Sevoflurane Product Image Figure 2. Global Sevoflurane Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sevoflurane Sales (2021-2032) & (K t) Figure 5. Global Sevoflurane Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Sevoflurane Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Generic Drug Image Figure 10. Original Drug Image Figure 11. Global Sevoflurane Sales Volume by Type (2021 VS 2025 VS 2032) & (K t) Figure 12. Global Sevoflurane Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sevoflurane Sales Volume Share by Type (2021-2032) Figure 14. Global Sevoflurane Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sevoflurane Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sevoflurane Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Other Medical Institutions Image Figure 19. Global Sevoflurane Sales Volume by Application (2021 VS 2025 VS 2032) & (K t) Figure 20. Global Sevoflurane Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Sevoflurane Sales Volume Share by Application (2021-2032) Figure 22. Global Sevoflurane Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sevoflurane Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Sevoflurane Sales Value Share by Application (2021-2032) Figure 25. Global Sevoflurane Sales by Region: 2021 VS 2025 VS 2032 (K t) Figure 26. Global Sevoflurane Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Sevoflurane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Sevoflurane Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Sevoflurane Sales Value (2021-2032) & (US$ Million) Figure 30. North America Sevoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Sevoflurane Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Sevoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Sevoflurane Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Sevoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Sevoflurane Sales Value (2021-2032) & (US$ Million) Figure 36. South America Sevoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Sevoflurane Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Sevoflurane Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Sevoflurane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Sevoflurane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Sevoflurane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Sevoflurane Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Sevoflurane Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • Original Drug
Applications
  • Hospitals
  • Other Medical Institutions
Companies covered
  • Abbott
  • Baxter
  • Maruishi
  • Jiangsu Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sevoflurane Sales Value (2021-2032)
  4. 1.2.2 Global Sevoflurane Sales Volume (2021-2032)
  5. 1.2.3 Global Sevoflurane Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sevoflurane Market Dynamics
  1. 2.1 Sevoflurane Industry Trends
  2. 2.2 Sevoflurane Industry Drivers
  3. 2.3 Sevoflurane Industry Opportunities and Challenges
  4. 2.4 Sevoflurane Industry Restraints
3 Sevoflurane Market by Company
  1. 3.1 Global Sevoflurane Company Revenue Ranking in 2025
  2. 3.2 Global Sevoflurane Revenue by Company (2021-2026)
  3. 3.3 Global Sevoflurane Sales Volume by Company (2021-2026)
  4. 3.4 Global Sevoflurane Average Price by Company (2021-2026)
  5. 3.5 Global Sevoflurane Company Ranking (2024-2026)
  6. 3.6 Global Sevoflurane Company Manufacturing Base and Headquarters
  7. 3.7 Global Sevoflurane Company Product Type and Application
  8. 3.8 Global Sevoflurane Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sevoflurane Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sevoflurane Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sevoflurane Market by Type
  1. 4.1 Sevoflurane Type Introduction
  2. 4.1.1 Generic Drug
  3. 4.1.2 Original Drug
  4. 4.2 Global Sevoflurane Sales Volume by Type
  5. 4.2.1 Global Sevoflurane Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sevoflurane Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sevoflurane Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sevoflurane Sales Value by Type
  9. 4.3.1 Global Sevoflurane Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sevoflurane Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sevoflurane Sales Value Share by Type (2021-2032)
5 Sevoflurane Market by Application
  1. 5.1 Sevoflurane Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Other Medical Institutions
  4. 5.2 Global Sevoflurane Sales Volume by Application
  5. 5.2.1 Global Sevoflurane Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sevoflurane Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sevoflurane Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sevoflurane Sales Value by Application
  9. 5.3.1 Global Sevoflurane Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sevoflurane Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sevoflurane Sales Value Share by Application (2021-2032)
6 Sevoflurane Regional Sales and Value Analysis
  1. 6.1 Global Sevoflurane Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sevoflurane Sales by Region (2021-2032)
  3. 6.2.1 Global Sevoflurane Sales by Region: 2021-2026
  4. 6.2.2 Global Sevoflurane Sales by Region (2027-2032)
  5. 6.3 Global Sevoflurane Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sevoflurane Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sevoflurane Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sevoflurane Sales Value by Region (2027-2032)
  9. 6.5 Global Sevoflurane Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sevoflurane Sales Value (2021-2032)
  12. 6.6.2 North America Sevoflurane Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sevoflurane Sales Value (2021-2032)
  15. 6.7.2 Europe Sevoflurane Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sevoflurane Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sevoflurane Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sevoflurane Sales Value (2021-2032)
  21. 6.9.2 South America Sevoflurane Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sevoflurane Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sevoflurane Sales Value Share by Country, 2025 VS 2032
7 Sevoflurane Country-level Sales and Value Analysis
  1. 7.1 Global Sevoflurane Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sevoflurane Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sevoflurane Sales by Country (2021-2032)
  4. 7.3.1 Global Sevoflurane Sales by Country (2021-2026)
  5. 7.3.2 Global Sevoflurane Sales by Country (2027-2032)
  6. 7.4 Global Sevoflurane Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sevoflurane Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sevoflurane Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sevoflurane Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sevoflurane Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sevoflurane Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sevoflurane Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sevoflurane Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sevoflurane Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sevoflurane Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sevoflurane Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sevoflurane Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sevoflurane Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sevoflurane Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sevoflurane Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sevoflurane Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sevoflurane Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sevoflurane Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sevoflurane Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sevoflurane Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sevoflurane Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sevoflurane Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sevoflurane Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sevoflurane Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sevoflurane Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sevoflurane Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sevoflurane Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sevoflurane Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sevoflurane Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sevoflurane Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sevoflurane Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sevoflurane Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sevoflurane Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sevoflurane Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sevoflurane Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sevoflurane Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sevoflurane Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sevoflurane Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sevoflurane Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sevoflurane Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sevoflurane Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sevoflurane Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sevoflurane Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sevoflurane Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sevoflurane Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sevoflurane Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sevoflurane Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sevoflurane Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sevoflurane Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sevoflurane Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sevoflurane Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sevoflurane Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sevoflurane Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sevoflurane Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sevoflurane Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sevoflurane Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sevoflurane Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sevoflurane Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sevoflurane Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sevoflurane Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sevoflurane Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sevoflurane Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sevoflurane Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sevoflurane Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sevoflurane Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sevoflurane Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sevoflurane Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sevoflurane Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sevoflurane Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sevoflurane Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sevoflurane Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sevoflurane Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sevoflurane Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sevoflurane Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sevoflurane Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sevoflurane Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sevoflurane Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sevoflurane Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sevoflurane Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sevoflurane Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sevoflurane Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sevoflurane Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sevoflurane Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sevoflurane Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sevoflurane Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sevoflurane Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sevoflurane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Sevoflurane Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Sevoflurane Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Sevoflurane Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Sevoflurane Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Maruishi
  14. 8.3.1 Maruishi Company Information
  15. 8.3.2 Maruishi Business Overview
  16. 8.3.3 Maruishi Sevoflurane Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Maruishi Sevoflurane Product Portfolio
  18. 8.3.5 Maruishi Recent Developments
  19. 8.4 Jiangsu Hengrui
  20. 8.4.1 Jiangsu Hengrui Company Information
  21. 8.4.2 Jiangsu Hengrui Business Overview
  22. 8.4.3 Jiangsu Hengrui Sevoflurane Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengrui Sevoflurane Product Portfolio
  24. 8.4.5 Jiangsu Hengrui Recent Developments
  25. 8.5 Lunan
  26. 8.5.1 Lunan Company Information
  27. 8.5.2 Lunan Business Overview
  28. 8.5.3 Lunan Sevoflurane Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lunan Sevoflurane Product Portfolio
  30. 8.5.5 Lunan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sevoflurane Value Chain Analysis
  2. 9.1.1 Sevoflurane Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sevoflurane Sales Mode & Process
  6. 9.2 Sevoflurane Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sevoflurane Distributors
  9. 9.2.3 Sevoflurane Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst